CNSystems Medizintechnik GmbH is a global leader in noninvasive hemodynamic monitoring technology for clinical and research applications. Their core technology CNAP® offers noninvasive and continuous beat-to-beat recordings of blood pressure, advanced hemodynamic parameters, and dynamic fluid management. Their high-quality product lines, which include branded devices such as Task Force® Touch CARDIO and CNAP® Monitor 500 HD, cater to patient monitoring, research, and diagnosis applications. CNSystems' capabilities in development, manufacturing, and supply of medical products are trusted by renowned clinical and research institutes, as well as global players. The last known investment, a €50.00K grant investment, was made on 01 May 2015 by EASME - EU Executive Agency for SMEs. With their noninvasive, easy-to-use, clinically validated, and cost-effective solutions, CNSystems meets the demand for improved patient safety and outcomes in situations where continuous parameters are required but invasive methods are not feasible.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Grant | €50.00K | 1 | EASME - EU Executive Agency for SMEs | 01 May 2015 |
Venture Round | Unknown | 1 | Gamma Capital Partners | 01 Dec 2002 |
No recent news or press coverage available for CNSystems Medizintechnik GmbH.